(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.

@article{Huang2014Epigallocatechin3gallateIE,
  title={(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.},
  author={Hsiu-Chen Huang and Mi-Hua Tao and Tzu-Min Hung and Jui-Chieh Chen and Zi-Jun Lin and Cheng Huang},
  journal={Antiviral research},
  year={2014},
  volume={111},
  pages={
          100-11
        }
}
Hepatitis B virus (HBV) is a major cause of liver disease and hepatocellular carcinoma. Chronic HBV infection is currently managed with either nucleoside/nucleotide-based or interferon-based therapies, but fails to clear infection in a substantial proportion of cases, and antiviral strategies targeting the early stages of infection are therefore required for the prevention of HBV infection. In this study, we examined some common phytochemicals and identified epigallocatechin-3-gallate (EGCG) as… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 32 CITATIONS

Inhibitory effect of silibinin on hepatitis B virus entry

  • Biochemistry and biophysics reports
  • 2018
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

NTCP opens the door for hepatitis B virus infection.

  • Antiviral research
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Anti-infective potential of catechins and their derivatives against viral hepatitis

  • Clinical and experimental vaccine research
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice

  • BMC Complementary and Alternative Medicine
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND